Search bioRxiv⌕ Search

Biology subjects

Townsend, J. P.

Publications and source records attributed to Townsend, J. P..

At least 19 recordsLinked to original sources

Signal, noise, and bias in phylogenetic inference:potential and limits to the resolution of phylogenetic trees in the phylogenomic era

Phylogenomic datasets assembled to resolve the Tree of Life now routinely span thousands of loci comprising millions of characters. Yet the persistence of incongruent topologies across such datasets reveals a fundamental truth of phylogenetics: not all data are equally informative. Here we derive analytical approaches that predict the relative impacts of phylogenetic signal, stochastic noise, and systematic bias on phylogenetic inference. We show that these three components exhibit divergent scaling properties with character sampling: signal and bias accumulate linearly, while noise accumulates nonlinearly with a concave trajectory. For some phylogenetic problems, substantial amounts of phylogenetic noise may eventually be overwhelmed by signal. For other phylogenetic problems--especially those involving deep divergences, short internodes, or constrained character-state space--the slope of signal accumulation can be so shallow that even signal from genome-scale data may never practically exceed noise. Moreover, linear accumulation of phylogenetic bias can in principle continuously overwhelm accumulation of signal at a lower slope with additional characters, regardless of dataset size. Applying our theory to empirical datasets, we show that anchored hybrid enrichment and ultraconserved element loci, like any loci, can exhibit signal that is overwhelmed by noise, and that character acquisition biases in some loci can further confound inference. Given the pervasive nature of incongruence in the phylogenomic era, our work provides a theoretical foundation for understanding the limits of inference, improving experimental design, and guiding efficient and accurate resolution of the Tree of Life.

evolutionary biology↗

Deconvolving mutation and selection reveals stage-specific drivers of thyroid cancer

ObjectiveMutational profiles of primary and metastatic thyroid cancer (THCA) have been examined by comparison of somatic mutation prevalences in the two stages, using P values to identify significant differences. However, prevalences and P values for mutations do not directly quantify the cancer effects of somatic variants. MethodsWe calculated cancer effect sizes accounting for substantial gene- and site-specific mutation rates, to quantify somatic selection across stages. This approach provides a direct measure of cancer-driving impact of new mutations and reveals the genes that drive tumorigenesis and progression, and whether mutations have greater effects in primary or metastatic THCA. ResultsTrinucleotide mutation profiles were similar between primary and metastatic THCA. Most canonical driver genes (BRAF, NRAS, TP53, ATM, EIF1AX, KMT2C, NF1, RBM10, ARID1A, PIK3CA, and NKX2-1) exhibited stronger selection during initial tumorigenesis (from organogenesis to primary THCA) than during progression (from primary to metastatic THCA). Notably, TERT mutations have been shown to be at higher prevalence in metastatic tumors, yet their strongest selection occurred earlier, during tumor initiation. In contrast, RET mutations exhibited the opposite trajectory, experiencing weaker selection during tumorigenesis but stronger selection during metastatic progression. ConclusionCancer effect size analysis revealed dynamic shifts in selective pressures across THCA evolution, distinguishing genes that drive initiation from those that promote metastatic progression. This evolutionary framework provides a quantitative basis for understanding THCA pathogenesis and provides guidance for stage-specific precision-medicine therapeutic strategies.

cancer biology↗

Somatic evolution of prostate cancer: mutation, selection, and epistasis across disease stages

BackgroundSomatic mutations involved in prostate cancer tumorigenesis and disease progression have been identified, but their evolutionary dynamics--including differential selective pressures across oncogenesis and metastatic spread--remain poorly understood. No prior study has systematically quantified the adaptive landscape from prostate organogenesis through tumor initiation and progression to metastatic castrate-resistant prostate cancer (mCRPC), nor characterized the selective epistatic interactions that structure this evolutionary trajectory. Methods and FindingsTo address this gap, we analyzed 2,704 low- and high-risk primary tumors and metastatic castration-resistant prostate cancers to quantify the mutation rates, mutational processes, and scaled selection coefficients of somatic mutations across disease stages. Trinucleotide mutational patterns were stable, but both mutation load and mutation rates increased with progression. In parallel, selective pressures on specific somatic mutations changed substantially, revealing a dynamic adaptive landscape. Stage-specific selective effects were associated with significant synergistic and antagonistic selective epistasis among key driver genes. Early selection on SPOP mutations in the BRD3 binding domain were under strong positive selection, and they increased selection for subsequent RHOA mutations while decreasing selection for TP53 mutations. Antagonistic selective epistasis was evident between mutations of CUL3 and both SPOP and PIK3CA. Mutations in KMT2C increased the selection for mutations in TP53, consistent with their frequent co-occurrence. Synergistic epistatic interactions between mutations of PTEN and both PIK3CA and AR support a strong therapeutic rationale for combined inhibition of PI3K/AR pathway in PTEN-deficient prostate cancers. ConclusionsThese findings provide a comprehensive map of the evolving selective and epistatic forces that shape prostate cancer progression across clinical stages. By distinguishing shifts in selection from changes in mutation rate and revealing the extents of cooperative and conflicting relationships among driver mutations, our work identifies critical points of vulnerability and informs that design of therapeutic strategies that anticipate and intercept the somatic evolutionary trajectory of prostate cancer.

cancer biology↗

Competing Subclones and Fitness Diversity Shape Tumor Evolution Across Cancer Types

Intratumor heterogeneity arises from ongoing somatic evolution complicating cancer diagnosis, prognosis, and treatment. Here we present TEATIME (estimating evolutionary events through single-timepoint sequencing), a novel computational framework that models tumors as mixtures of two competing cell populations: an ancestral clone with baseline fitness and a derived subclone with elevated fitness. Using cross-sectional bulk sequencing data, TEATIME estimates mutation rates, timing of subclone emergence, relative fitness, and number of generations of growth. To quantify intratumor fitness asymmetries, we introduce a novel metric--fitness diversity--which captures the imbalance between competing cell populations and serves as a measure of functional intratumor heterogeneity. Applying TEATIME to 33 tumor types from The Cancer Genome Atlas, we revealed divergent as well as convergent evolutionary patterns. Notably, we found that immune-hot microenvironments constraint subclonal expansion and limit fitness diversity. Moreover, we detected temporal dependencies in mutation acquisition, where early driver mutations in ancestral clones epistatically shape the fitness landscape, predisposing specific subclones to selective advantages. These findings underscore the importance of intratumor competition and tumor-microenvironment interactions in shaping evolutionary trajectories, driving intratumor heterogeneity. Lastly, we demonstrate that TEATIME-derived evolutionary parameters and fitness diversity offer novel prognostic insights across multiple cancer types.

bioinformatics↗

AURKA inhibition amplifies DNA replication stress to foster WEE1 kinase dependency and synergistic antitumor effects with WEE1 inhibition in cancers

Highly elevated expression of the oncogene Aurora kinase A (AURKA) occurs in numerous human cancers harboring defective p53, nominating AURKA as a potential vulnerability in TP53-mutated cancer. However, clinical trials have indicated modest monotherapy activity of AURKA inhibitors. Here, we demonstrate that AURKA inhibition promotes phosphorylation of Replication Protein A (RPA), resulting in stalled DNA replication fork progression and eliciting a replication stress response in multiple TP53-mutated models, creating a druggable dependence on the mitotic checkpoint kinase WEE1. Combined inhibition of AURKA and WEE1 synergistically enhanced replication stress, tumor-specific apoptotic cell death, and mitotic catastrophe, and lead to marked tumor regression in cell line- and patient-derived xenograft models of TP53-mutated cancer. Our findings define enhanced DNA replication stress as underlying the strong synergy between AURKA and WEE1 inhibitors and offer preclinical confirmation of efficacy, indicating high potential for clinical translation of this synthetic lethal strategy for TP53-mutated carcinomas. Statement of significanceWe demonstrate that a small molecule AURKA inhibitor amplifies DNA replication stress in TP53-mutated carcinomas. This amplification of DNA replication stress can be leveraged this for synthetic lethal therapy in a combination with WEE1 inhibition that enhances antitumor effects in in vitro, in xenografts and in patient-derived xenograft models, advancing a promising novel combination therapy.

cancer biology↗

Comparative transcriptional analysis reveals gene expression changes in spore germination of opportunistic pathogenic fungi

In opportunistic human pathogenic fungi, changes in gene expression play a crucial role in the progression of growth stages from early spore germination through host infection. Comparative transcriptomics between diverse fungal pathogens and non-pathogens provided insights into regulatory mechanisms behind the initiation of infectious processes. We examined the gene expression patterns of 3,845 single-copy orthologous genes (SCOGs) across five phylogenetically distinct species, including the opportunistic human pathogens Fusarium oxysporum, Aspergillus fumigatus, and A. nidulans, and nonpathogenic species Neurospora crassa and Trichoderma asperelloides, at four sequential stages of spore germination. Ancestral status of gene expression was inferred for nodes along the phylogeny. By comparing expression patterns of the SCOGs with their most recent common ancestor (MRCA), we identified genes that exhibit divergent levels of expression during spore germination when comparing fungal pathogens to non-pathogens. We focused on genes related to the MAPK pathway, nitrogen metabolism, asexual development, G-protein signaling, and conidial-wall integrity. Notably, orthologs of the transcription activator abaA, a known central regulator of conidiation, exhibited significant divergence in gene expression in F. oxysporum. This dramatic expression change in abaA was accompanied by structural modifications of phialides in F. oxysporum, and revealed how these changes impact development of offspring, formation of aerial hyphae, spore production, and pathogenicity. Our research provides insights into ecological adaptations observed during the divergence of these species, specifically highlighting how divergence in gene expression during spore germination contributes to their ability to thrive in distinct environments. Author SummaryThe fungi of the phylum Ascomycota include plant and animal pathogens, endophytes, and saprotrophs, some of which are model organisms for biological investigation, and usually have abundant genomic and transcriptomic data. In this study, transcriptomics was studied during spore germination in five species: the opportunistic human pathogens Fusarium oxysporum, Aspergillus fumigatus, and Aspergillus nidulans, and the nonpathogenic species Neurospora crassa and Trichoderma asperelloides. We have inferred divergence in gene expression for 3,845 single-copy orthologous genes (SCOGs) along these lineages. Genes related to the MAPK pathway, nitrogen metabolism, conidia-related regulators, G protein signaling, and conidial-wall integrity exhibited dramatic expression shifts in the lineages of the opportunistic human pathogens evolving towards true pathogenic species. Notably, abaA, a known central regulator of conidiation, exhibited striking divergence in expression in the opportunistic pathogens, resulting in structural modifications in phialides that were more similar to pathogenic species, and revealing how these changes impact development of aerial hyphal formation, spore production, and pathogenicity. These findings provide insights into ecological adaptations resulting from divergence in gene expression, and reveal dynamic transcriptional changes, which may be crucial for the adaptation of opportunistic pathogens to changing environments. By elucidating the shifting roles of abaA, our research contributes to a deeper understanding of the divergence mechanisms underlying development and pathogenicity in fungi.

microbiology↗

DMEM and EMEM are suitable surrogate media to mimic host environment and expand leptospiral pathogenesis studies using in vitro tools

Pathogenic Leptospira species can survive and thrive in a wide range of environments. Distinct environments expose the bacteria to different temperatures, osmolarities, and amounts and sources of nutrition. However, leptospires are mostly cultured, in a laboratory setting under in vitro conditions that do not reflect natural environments. This constraint on laboratory cultures limits the applicability of in vitro studies to the understanding of even simple pathogenic processes. Here we report, investigate, and identify a medium and conditions that mimic the host environment during leptospirosis infection, expanding the available in vitro tools to evaluate leptospiral pathogenesis. We quantified genome-wide gene expression of pathogenic Leptospira interrogans cultured in different in vitro media compositions (EMJH, DMEM, EMEM, and HAN). Using EMJH as standard, we compared gene expression in these compositions to genome-wide gene expression gathered in a host environment: whole blood (WB) of hamsters after infection with pathogenic leptospires. Leptospires cultured in DMEM and EMEM media shared 40% and 47% of all differentially expressed genes (DEGs) of leptospires present within WB (FDR<0.01), while leptospires cultured in HAN media only shared 20% of DEGs with those from WB. Furthermore, gene and pathway expression of leptospires cultured on DMEM and EMEM media exhibited a better correlation with leptospires grown in WB, including promoting expression of a similar leptospiral lipid A profile to the one identified directly in host tissues. Taken together, these results indicate that commercial cell-culture media EMEM or DMEM are better surrogates for in vivo pathogenic studies than EMJH or HAN media in Leptospira. These alternative culture conditions, using media that are a standard supply worldwide, provide a reproducible and cost-effective approach that can accelerate research investigation and reduce the number of animal infections necessary for basic research of leptospirosis.

microbiology↗

Entrenchment and contingency in neutral protein evolution with epistasis

Protein sequence evolution in the presence of epistasis makes many previously acceptable amino acid residues at a site unfavorable over time. This phenomenon of entrenchment has also been observed with neutral substitutions using Potts Hamiltonian models. Here, we show that simulations using these models often evolve non-neutral proteins. We introduce a Neutral-with-Epistasis (NxE) model that incorporates purifying selection to conserve fitness, a requirement of neutral evolution. NxE protein evolution revealed a surprising lack of entrenchment, with site-specific amino-acid preferences remaining remarkably conserved, in biologically realistic time frames despite extensive residue coupling. Moreover, we found that the overdispersion of the molecular clock is caused by rate variation across sites introduced by epistasis in individual lineages, rather than by historical contingency. Therefore, substitutional entrenchment and rate contingency may indicate that adaptive and other non-neutral evolutionary processes were at play during protein evolution.

evolutionary biology↗

Tobacco smoke alters the landscape of mutation, selection, and epistasis in lung adenocarcinoma

The mutagenic effects of tobacco smoke are well-reported. However, tobacco smoke also likely alters the somatic selective pressures that drive lung cancer evolution, and these altered pressures have never been quantified nor compared to the oncogenic effects of tobacco-induced mutagenesis. This comparison is necessary for prediction of targeted therapy efficacy given exposure history. Here, we estimated background mutation rates, somatic selection, and selective epistasis for 21 driver genes in ever- and never-smoker lung adenocarcinoma (ES-and NS-LUAD). As expected, mutation rates were gene-specifically elevated in ES-LUAD. However, variant prevalence differences between ES- and NS-LUAD could not be explained by differential mutagenesis. KRAS, KEAP1, and STK11 mutations were more strongly selected in ES-LUAD. EGFR, PIK3CA, and SMAD4 mutations were more strongly selected in NS-LUAD, wherein EGFR mutations were associated with upregulation of epithelial-mesenchymal transition--a functional consequence specific to exposure history. Epistasis was pervasive and context-dependent: ES-LUAD exhibited more synergy and less antagonism, implying a broader, more navigable adaptive landscape than NS-LUAD. We also performed the first systematic quantification of higher-order-than-pairwise epistasis, revealing sub-additive and emergent synergies that shape cancer evolution. Our results disambiguate the mutagenic and selective effects of tobacco smoke, demonstrating how environmental insults reshape cancer evolution and enabling prediction of therapeutic efficacy based on smoking history and somatic genotype. Author SummarySmoking is a well-known cause of lung cancer because it increases the number of mutations in lung cells. But tobacco smoke also causes inflammation and other physiological changes that might influence how tumors evolve. Using DNA from lung tumors, we asked whether these changes make certain mutations more helpful to cancer growth and thereby better targets for therapy. We also asked whether some mutations were more helpful to cancer growth in those who havent smoked. To do so, we estimated not only how often mutations occurred, but also how strongly they were favored during cancer development. Focusing on 21 key lung cancer genes, including KRAS, EGFR, and TP53, we found that mutations in some, such as KRAS and KEAP1 were more strongly favored in smokers. Mutations in genes such as EGFR and PIK3CA were more strongly favored in non-smokers, where they were also linked to non-smoker-specific changes in gene activity. We also found that mutations in tumors interact differently depending on smoking history: smokers tumors showed more cooperation between mutations, which may help them evolve in more flexible ways. This study shows how smoking reshapes the genetic paths lung cancers take--and why a patients smoking history matters when choosing targeted treatments. Understanding these evolutionary patterns can help improve treatment decisions and lead to more personalized care for lung cancer patients.

genomics↗

Mutation of NOTCH1 is selected within normal esophageal tissues, yet leads to selective epistasis suppressive of further evolution into cancer

BackgroundSomatic mutations commonly accumulate in histologically normal tissues and contribute to cancer development. However, many mutations that are common in normal tissue are also found in cancers from the same organ, making their role in malignant progression unclear. To address this, we asked whether such mutations increase cell proliferation and survival to different degrees at different steps of esophageal tumor development, and whether they alter selection for other driver mutations. MethodsWe used a quantitative evolutionary framework to distinguish underlying mutation rate from selection across two steps of esophageal development: from organogenesis to clonal histologically normal esophageal epithelium, and from that tissue to esophageal squamous-cell carcinoma. Analyzing sequence data from 2171 samples, we estimated step-specific selection on recurrent somatic mutations, corresponding to increased cellular division and survival, and tested whether mutations in one gene earlier in the trajectory changed selection for mutations on another. We additionally examined somatic copy-number alterations and single-cell transcriptomic profiles to contextualize these evolutionary patterns within broader genomic and cellular changes during progression. ResultsNOTCH1 mutations were strongly selected during the clonal expansion of histologically normal esophageal epithelium, explaining their high prevalence in that tissue. However, for the first time, we show that there is little to no positive selection for NOTCH1, NOTCH2, and FAT1 mutations during progression from clonal histologically normal esophageal tissue to esophageal squamous-cell carcinoma in humans, leading to a conclusion that these alterations promote clonal expansion in normal tissue, but do not drive malignant progression from established normal clones. Moreover, we provide a somatic genetic basis for this step-specific effect: we demonstrate for the first time that mutations in NOTCH1 exhibit antagonistic epistasis with mutations of TP53 and RB1, reducing selection for these key tumor suppressor alterations during tumor development. Consistent with this model, copy-number alterations associated with later ESCC progression were more strongly selected in TP53-mutant samples, supporting the idea that TP53 disruption promotes a genomic context more permissive for malignant evolution. ConclusionsEarly somatic mutations can promote clonal expansion in normal tissue without promoting cancer, and in some cases may limit progression by reducing selection for later driver events. NOTCH1 and other genes can shape evolutionary trajectories in ways that ultimately constrain malignant progression. By separating mutation rate from selection, quantifying step-specific genetic interactions, and considering broader changes in genomic and cellular context, our study shows that the effects of recurrent mutations depend strongly on disease stage and mutational context--what promotes clonal expansion in normal tissue may later impede growth or survival in tumors. These insights underscore the need for precision strategies that account for the shifting fitness landscape across premalignant and malignant stages, informing early detection, prevention, and therapeutic prioritization.

cancer biology↗

Purifying selection and adaptive evolution proximate to the zoonosis of SARS-CoV-1 and SARS-CoV-2

Over the past two decades the pace of spillovers from animal viruses to humans has accelerated, with COVID-19 becoming the most deadly zoonotic disease in living memory. Prior to zoonosis, it is conceivable that the virus might largely be subjected to purifying selection, requiring no additional selective changes for successful zoonotic transmission. Alternatively, selective changes occurring in the reservoir species may coincidentally preadapt the virus for human-to-human transmission, facilitating spread upon cross-species exposure. Here we quantify changes in the genomes of SARS-CoV-2 and SARS-CoV-1 proximate to zoonosis to evaluate the selection pressures acting on the viruses. Application of molecular-evolutionary and population-genetic approaches to quantify site-specific selection within both SARS-CoV genomes revealed strong purifying selection across many genes at the time of zoonosis. Even in the viral surface-protein Spike that has been fast-evolving in humans, there is little evidence of positive selection proximate to zoonosis. Nevertheless, in SARS-CoV-2, NSP12, a core protein for viral replication, exhibited a region under adaptive selection proximate to zoonosis. Furthermore, in both SARS-CoV-1 and SARS-CoV-2, regions of adaptive selection proximate to zoonosis were found in ORF7a, a putative Major Histocompatibility Complex modulatory gene. These findings suggest that these replication and immunomodulatory proteins have played a previously underappreciated role in the adaptation of SARS coronaviruses to human hosts.

evolutionary biology↗

Orphan genes are clustered with allorecognition loci and may be involved in incompatibility and speciation in Neurospora

Lineage-specific genes (LSGs) have long been postulated to play roles in the establishment of genetic barriers to intercrossing and speciation. However, there is a lack of working hypotheses as to how they might play that role. In the genome of Neurospora crassa, most of the 670 Neurospora LSGs that are aggregated adjacent to the telomeres are clustered with 61% of the HET-domain genes, which regulate self-recognition and define vegetative incompatibility groups. Among the 342 LSGs that are dynamically expressed during both asexual and sexual phases, 64% were detectable on unusual carbon sources such as furfural and HMF--wildfire-produced chemicals that are a strong inducer of sexual development. Expression of a significant portion of the LSGs was sensitive to light and temperature, factors that regulate the switch from asexual to sexual reproduction. Furthermore, expression of the LSGs was significantly affected in the knockouts of adv-1 and pp-1 that regulate hyphal communication, and expression of more than one quarter of the LSGs was affected by perturbation of the mating locus. Accordingly, we propose a gene-by-environment interaction model encouraging further investigation of the roles of LSGs and HET-domain genes in speciation in Neurospora. This gene-by-environment interaction model emphasizes the roles of the LSGs in response to genetic and environmental factors, leading to the regulation of the switch from the asexual growth and fusion, such that vegetative incompatibility governed by allorecognition promotes allelic homogeneity, sexual reproduction, and outbreeding, whereas VI repression and meiotic recombination promotes allelic polymorphism.

evolutionary biology↗

Pairwise and higher-order epistatic effects among somatic cancer mutations across oncogenesis

Cancer occurs as a consequence of multiple somatic mutations that lead to uncontrolled cell growth. Mutual exclusivity and co-occurrence of mutations imply--but do not prove--that they can exert synergistic or antagonistic epistatic effects on oncogenesis. Knowledge of these interactions, and the consequent trajectories of mutation and selection that lead to cancer has been a longstanding goal within the cancer research community. Recent research has revealed mutation rates and scaled selection coefficients for specific recurrent variants across many cancer types. However, estimation of pairwise and higher-order effects--essential to estimation of the trajectory of likely cancer genotoypes--has been a challenge. Therefore, we have developed a continuous-time Markov chain model that enables the estimation of mutation origination and fixation (flux), dependent on somatic cancer genotype. Coupling the continuous-time Markov chain model with a deconvolution approach provides estimates of underlying mutation rates and selection across the trajectory of oncogenesis. We demonstrate computation of fluxes and selection coefficients in a somatic evolutionary model for the four most frequently variant driver genes (TP53, LRP1B, KRAS and STK11) from 565 cases of lung adenocarcinoma. Our analysis reveals multiple antagonistic epistatic effects that reduce the possible routes of oncogenesis, and inform cancer research regarding viable trajectories of somatic evolution whose progression could be forestalled by precision medicine. Synergistic epistatic effects are also identified, most notably in the somatic genotype TP53+LRP1B for mutations in the KRAS gene, and in somatic genotypes containing KRAS or TP53 mutations for mutations in the STK11 gene. Large positive fluxes of KRAS variants were driven by large selection coefficients, whereas the flux toward LRP1B mutations was substantially aided by a large mutation rate for this gene. The approach enables inference of the most likely routes of site-specific variant evolution and estimation of the strength of selection operating on each step along the route, a key component of what we need to know to develop and implement personalized cancer therapies.

cancer biology↗

Cancer relevance of human genes

BackgroundIt is unclear how many of genes contribute to the biology of cancer. We hypothesize that genes that interact with core cancer gene (CCG) in a protein-protein interaction network (PPI) may have functional importance. MethodsWe categorized genes into 1- (n=6791), 2- (n=7724), 3- (n=1587), and >3-steps (n=362) removed from the nearest CCG in the STRING PPI and demonstrate that the cancer-biology related functional contribution of the genes in these different neighborhood categories decreases as their distance from the CCGs increases. ResultsGenes closer to cancer genes manifest greater connectedness in the network, show greater importance in maintaining cell viability in a broad range of cancer cells in vitro, are also under greater negative germline selection pressure in the healthy populations, and have higher somatic mutation frequency and cancer effect. ConclusionsApproximately 70% of human genes are 1 or 2 steps removed from cancer genes in protein network and show functional importance in cancer-biology. These results suggest that the universe of cancer-relevant genes extends to thousands of genes that can contribute functional effects when dysregulated.

genomics↗

Attribution of Cancer Origins to Endogenous, Exogenous, and Actionable Mutational Processes

Mutational processes in tumors leave tell-tale genomic signatures composed of "passenger" mutations and mutations that have quantifiable effects on the proliferation and survival of cancer cell lineages. We identify the contributions of mutational processes to each oncogenic variant, quantifying responsibility for origination of changes at oncogenic variant sites contributing to tumorigenesis in 23 cancer types. We demonstrate that the variants driving melanomas and lung cancers are predominantly attributable to the actionable, preventable, exogenous mutational processes of ultraviolet light and tobacco exposure, whereas gliomas and prostate adenocarcinomas are largely attributable to endogenous processes associated with aging. Preventable mutations associated with pathogen exposure and APOBEC activity account for a large proportion of the cancer effect within head and neck, bladder, cervical, and breast cancers. These attributions complement epidemiological approaches--revealing the burden of cancer driven by single-nucleotide variants caused by either endogenous or exogenous, non-actionable or actionable processes, and crucially inform cancer prevention.

cancer biology↗

Field testing of biohybrid robotic jellyfish to demonstrate enhanced swimming speeds

Biohybrid robotic designs incorporating live animals and self-contained microelectronic systems can leverage the animals own metabolism to reduce power constraints and act as natural chassis and actuators with damage tolerance. Previous work established that biohybrid robotic jellyfish can exhibit enhanced speeds up to 2.8 times their baseline behavior in laboratory environments. However, it remains unknown if the results could be applied in natural, dynamic ocean environments and what factors can contribute to large animal variability. Deploying this system in the coastal waters of Massachusetts, we validate and extend prior laboratory work by demonstrating increases in jellyfish swimming speeds up to 2.3 times greater than their baseline, with absolute swimming speeds up to 6.6 {+/-} 0.3 cm s-1. These experimental swimming speeds are predicted using a hydrodynamic model with morphological and time-dependent input parameters obtained from field experiment videos. The theoretical model can provide a basis to choose specific jellyfish with desirable traits to maximize enhancements from robotic manipulation. With future work to increase maneuverability and incorporate sensors, biohybrid robotic jellyfish can potentially be used track environmental changes in applications for ocean monitoring.

bioengineering↗

Colloblasts act as a biomechanical sensor for suitable prey in Pleurobrachia

Ctenophores are a group of largely-planktonic, gelatinous carnivores whose most common method of prey capture is nearly a phylum-defining trait. Tentaculate ctenophores release an unknown proteinaceous adhesive from specialised colloblast cells lining their tentacles following prey contact with the tentacles. There exist no extant studies of the mechanical properties of colloblast adhesive. We use live microscopy techniques to visualise adhesion events between Pleurobrachia pileus colloblasts and probes of different surface chemistries in response to probing with varying contact areas. We further define two mechanisms of adhesion termination upon probe retraction. Adapting a technique for measuring surface tension, we examine the adhesive strength of tentacles in the ctenophore Pleurobrachia bachei under varying pH and bonding time conditions, and demonstrate the destructive exhaustion of colloblast adhesive release. We find that colloblast-mediated adhesion is rapid, and that the bonding process is robust against shifts in ambient pH. However, we find that the Pleurobrachia colloblast adhesive system is among the weakest biological adhesive systems yet described. We place this surprising observation into a broader ecophysiological context by modeling prey capture for prey of a range of sizes. We find that limited use of colloblast adhesive with high surface area contact is suitable both for capturing appropriately sized prey and rejecting, by detachment, prey above a certain size threshold. This allows Pleurobrachia, lacking a mechanism to directly "see" potential prey they are interacting with, to invest in capturing only prey of an appropriate size, decreasing the risk of injury. Summary statementCtenophore colloblast adhesive is found to be strong, but few colloblasts are simultaneously active, producing a weakly-adhering system. A physical model demonstrates how such a system may filter unsuitable prey.

zoology↗

Identifying Modules of Cooperating Cancer Drivers

AbstractIdentifying cooperating modules of driver alterations can provide biological insights to cancer causation and would advance the development of effective personalized treatments. We present Cancer Rule-Set Optimization (CRSO) for inferring the combinations of alterations that cooperate to drive tumor formation in individual patients. Application to 19 TCGA cancer types found a mean of 11 core driver combinations per cancer, comprising 2-6 alterations per combination, and accounting for a mean of 70% of samples per cancer. CRSO departs from methods based on statistical cooccurrence, which we demonstrate is a suboptimal criterion for investigating driver cooperation. CRSO identified well-studied driver combinations that were not detected by other approaches and nominated novel combinations that correlate with clinical outcomes in multiple cancer types. Novel synergies were identified in NRAS-mutant melanomas that may be therapeutically relevant. Core driver combinations involving NFE2L2 mutations were identified in four cancer types, supporting the therapeutic potential of NRF2 pathway inhibition. CRSO is available at https://github.com/mikekleinsgit/CRSO/.Competing Interest StatementThe authors have declared no competing interest.View Full Text

cancer biology↗